Krystal Biotech Inc (KRYS)
163.99
+0.21
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
163.99
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Max Drawdown (5Y): 53.42% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 53.42% |
March 31, 2024 | 53.42% |
February 29, 2024 | 53.42% |
January 31, 2024 | 53.42% |
December 31, 2023 | 53.42% |
November 30, 2023 | 53.42% |
October 31, 2023 | 53.42% |
September 30, 2023 | 53.42% |
August 31, 2023 | 53.42% |
July 31, 2023 | 53.42% |
June 30, 2023 | 53.42% |
May 31, 2023 | 53.42% |
April 30, 2023 | 53.42% |
March 31, 2023 | 53.42% |
February 28, 2023 | 53.42% |
January 31, 2023 | 53.42% |
December 31, 2022 | 53.42% |
November 30, 2022 | 53.42% |
October 31, 2022 | 53.42% |
September 30, 2022 | 53.42% |
August 31, 2022 | 53.42% |
July 31, 2022 | 53.42% |
June 30, 2022 | 53.42% |
May 31, 2022 | 53.42% |
April 30, 2022 | 53.42% |
Date | Value |
---|---|
March 31, 2022 | 53.42% |
February 28, 2022 | 53.42% |
January 31, 2022 | 53.42% |
December 31, 2021 | 53.42% |
November 30, 2021 | 53.42% |
October 31, 2021 | 46.65% |
September 30, 2021 | 46.65% |
August 31, 2021 | 46.65% |
July 31, 2021 | 46.65% |
June 30, 2021 | 46.65% |
May 31, 2021 | 46.65% |
April 30, 2021 | 46.65% |
March 31, 2021 | 46.65% |
February 28, 2021 | 46.65% |
January 31, 2021 | 46.65% |
December 31, 2020 | 46.65% |
November 30, 2020 | 46.65% |
October 31, 2020 | 46.65% |
September 30, 2020 | 46.65% |
August 31, 2020 | 46.65% |
July 31, 2020 | 46.65% |
June 30, 2020 | 46.65% |
May 31, 2020 | 46.65% |
April 30, 2020 | 46.65% |
March 31, 2020 | 46.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
28.43%
Minimum
May 2019
53.42%
Maximum
Nov 2021
47.64%
Average
50.03%
Median
Max Drawdown (5Y) Benchmarks
Axsome Therapeutics Inc | 81.26% |
Catalyst Pharmaceuticals Inc | 64.87% |
EyePoint Pharmaceuticals Inc | 93.95% |
Madrigal Pharmaceuticals Inc | 82.20% |
Viking Therapeutics Inc | 89.26% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 23.98 |
Beta (5Y) | 0.9069 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 64.86% |
Historical Sharpe Ratio (5Y) | 0.5255 |
Historical Sortino (5Y) | 1.269 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.21% |